A pathologist is reviewing core needle biopsy specimens from four different adult patients with newly diagnosed mesenchymal neoplasms. Match each characteristic microscopic and immunohistochemical or molecular description with its definitive pathologic diagnosis.
- Monomorphic spindle cells in a dense storiform ('cartwheel') architecture deeply infiltrating subcutaneous adipose tissue; diffusely positive for CD34Dermatofibrosarcoma protuberans
- Biphasic or monophasic spindle cell proliferation with scant cytoplasm; molecular analysis confirms a t(X;18)(p11;q11) chromosomal translocationSynovial sarcoma
- Fascicles of uniform spindle cells with prominent perinuclear vacuolization located in the gastrointestinal muscularis propria; diffusely positive for KIT (CD117) and DOG1Gastrointestinal stromal tumor
- Bland spindle cells separated by bands of keloidal collagen with prominent staghorn vessels; strong nuclear positivity for STAT6Solitary fibrous tumor
Answer
The correct pairings are: the storiform CD34-positive lesion is Dermatofibrosarcoma protuberans; the t(X;18) translocation lesion is Synovial sarcoma; the KIT/DOG1-positive lesion is Gastrointestinal stromal tumor; and the STAT6-positive keloidal lesion is Solitary fibrous tumor.
Each described mesenchymal tumor possesses highly specific, definitive diagnostic criteria. Dermatofibrosarcoma protuberans is characterized by CD34 positivity and a storiform pattern infiltrating adipose tissue. Synovial sarcoma is defined molecularly by the t(X;18) translocation. Gastrointestinal stromal tumors are driven by KIT or PDGFRA mutations, rendering them strongly positive for KIT (CD117) and DOG1. Solitary fibrous tumors are defined by a NAB2-STAT6 gene fusion, which is detected via strong nuclear STAT6 immunohistochemical staining alongside characteristic staghorn vasculature.
Step-by-Step Solution
Key Concept
The pathologic diagnosis of mesenchymal neoplasms relies heavily on specific immunohistochemical markers (e.g., STAT6, CD117, CD34) and molecular cytogenetics (e.g., t(X;18) translocation) to differentiate tumors with overlapping spindle cell morphology.